The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review
Abstract
Background: Synthetic benzimidazole opioids (BOs) are highly potent µ-opioid receptor agonists with heroin-like effects. Isotonitazene was first available in 2019 in the drug market, although new analogs have multiplied recently. The authors aimed to identify BO use trends and gather toxicological data from BO-related cases to assist in clinical and forensic investigations. Methods: A systematic literature search was conducted according to the PRISMA guidelines. PubMed and Scopus databases were accessed in October 2021 to identify scientific reports of BO-related intoxication and fatalities. Publication dates, case descriptions, symptoms, autopsy findings, and concentrations of BOs and metabolites in biological matrices were compiled. Results: Data from 8 case reports with 93 fatalities involving isotonitazene (n = 65), metonitazene (n = 20), etonitazepyne (N-pyrrolidino etonitazene) (n = 8), flunitazene (n = 4), and/or butonitazene (n = 1), and 1 acute intoxication involving etonitazepyne were collected. Autopsy findings included pulmonary congestion/high lung weight (66%), cardiomegaly/high cardiac weight (39%), cerebral edema (22%), gastric contents in the airways (22%), and organ congestion (22%). Median peripheral blood concentrations were 1.7 ng/mL for isotonitazene (0.4–9.5 ng/mL, n = 13), 5.4 ng/mL for metonitazene (0.52–33 ng/mL, n = 17), 5.4 ng/mL for etonitazepyne (2.4–8.3 ng/mL, n = 2), 1.3 ng/mL for flunitazene (0.58–2.1 ng/mL, n = 2), and 3.2 ng/mL for butonitazene (n = 1). Central nervous system depressants were almost always coadministered. Conclusions: Isotonitazene was predominant in cases from 2019 to mid-2020 and was replaced by metonitazene after scheduling in the United States. Typical findings on opioid overdoses have been reported. Peripheral blood concentrations were consistent with a potency similar to that of fentanyl. These results must be interpreted carefully, considering the scarcity of reports on BO-related cases and drug co-exposures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“De Luca et al. [10] demonstrated that isotonitazene had longer-lasting effects than fentanyl.”
From Nitazenes: review of comparative pharmacology and antagonist action (2025) · cites this paper as [10]
In the citing paper
“etazene, detected by WEDINOS in 2021 [9]”
From Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples (2025) · cites this paper as [9]
In the citing paper
“The presence of nitazenes within counterfeit pills further increases overdose risk because users may unknowingly consume highly potent opioids without established opioid tolerance [7].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [7]
In the citing paper
“Clinical concern surrounding these compounds stems primarily from side effect profiles including respiratory depression, particularly in individuals unaware of exposure or in cases involving co-ingestion of additional sedating substances [7].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [7]
In the citing paper
“Nitazene analogs represent a new class of synthetic opioids that are associated with a high overdose risk related to high potency and increased prevalence worldwide.”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [7]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,731 · cited 1×
“38 The PB concentrations were not significantly different from those reported by Mueller et al 36 [t(11) = 0.”
ResultSex differences, gender and addiction
Becker, J. B., McClellan, M. L., & Reed, B. G. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23963 · Cited by 557
Stein, C. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093100 · Cited by 480
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
Schulz, M., Schmoldt, A., Andresen-Streichert, H., & Iwersen-Bergmann, S. (2020) · Critical Care · doi:10.1186/s13054-020-02915-5 · Cited by 390
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643e1 · Cited by 387
Heckbert, S. R., Post, W., Pearson, G. D. N., Arnett, D. K., Gomes, A. S., Jerosch-Herold, M., Hundley, W. G., Lima, J. A., & Bluemke, D. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.072 · Cited by 292
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000324 · Cited by 283
Hypertension and Heart Failure
Slivnick, J., & Lampert, B. C. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.06.007 · Cited by 242
Research works printed but not linked: 2
- 2020, Schedules of controlled substances: temporary placement of isotonitazene in schedule I, Fed Regist., 85, 51342
- Pucci, 2021, Severe toxicity involving N-pyrrolidino etonitazene in the United Kingdom-a case report, Clin Toxicol (Phila).
Cited by
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Amaducci, A., Aldy, K., Campleman, S. L., Li, S., Meyn, A., Abston, S., Culbreth, R. E., Krotulski, A., Logan, B., Wax, P., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.31264 · Cited by 84
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Pergolizzi Jr, J., Raffa, R., LeQuang, J. A. K., Breve, F., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.40736 · Cited by 81
“Novel psychoactive substances (NPS), including “novel” synthetic opioid analogs such as the re-emergence of the older nitazene drugs, are considered the driver in the recent upward trends in overdose mortality in the United States [5].”
BackgroundInfluentialSynthetic Cathinones and Neurotoxicity Risks: A Systematic Review
Daziani, G., Faro, A. F. L., Montana, V., Goteri, G., Pesaresi, M., Bambagiotti, G., Montanari, E., Giorgetti, R., & Montana, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076230 · Cited by 69
Self-citationToxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review
de Oliveira, M. C., Vides, M. C., Lassi, D. L. S., Torales, J., Ventriglio, A., Bombana, H. S., Leyton, V., Périco, C. D. A.-M., Negrão, A. B., Malbergier, A., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13070990 · Cited by 61
“Autopsy examinations demonstrated that pulmonary congestion, cardiomegaly, and cerebral edema associated with isotonitazene, followed by metonitazene, were also toxic effects of synthetic opioids [99].”
BackgroundSchumann, J. L., Syrjanen, R., Alford, K., Mashetty, S., Castle, J. W., Rotella, J., Maplesden, J., & Greene, S. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac062 · Cited by 61
Metadata
- Authors
- Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J.
- Affiliations
- Marche Polytechnic University (IT)
- Ospedale Infermi di Rimini (IT)
- Istituto Superiore di Sanità (IT)
- Unit of Forensic Toxicology, Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy;
- Corresponding author
- Montanari, Eva
- Busardò, Francesco Paolo
- Venue
- Therapeutic Drug Monitoring
- Published
- 2022-08
- Volume
- 44
- Issue
- 4
- Pages
- 494-510
- ISSN
- 0163-4356 (ISSN-L)
- OpenAlex
- W4211118532
- Cited by
- 89
- References
- 43
- Citations by year
- 2026: 16 · 2025: 28 · 2024: 22 · 2023: 16 · 2022: 7
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Therapeutic Drug Monitoring (publishedVersion)
- PubMed (publishedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- isotonitazene, opioid overdose, acute poisoning, autopsy findings, blood concentration, drug scheduling, central nervous system depressants, forensic toxicology, opioid analogs
- MeSH terms
- Analgesics, Opioid, Benzimidazoles, Cause of Death, Heroin, Fentanyl, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review. https://app.cochat.ai/papers/10.1097/ftd.0000000000000970
- The paper
- Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022). Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000000970
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.